Assenagon Asset Management’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $742K | Buy |
256,861
+38,427
| +18% | +$111K | ﹤0.01% | 951 |
|
|
2025
Q1 | $470K | Sell |
218,434
-1,553
| -0.7% | -$3.34K | ﹤0.01% | 1007 |
|
|
2024
Q4 | $851K | Sell |
219,987
-6,488
| -3% | -$25.1K | ﹤0.01% | 1106 |
|
|
2024
Q3 | $1.48M | Sell |
226,475
-383,554
| -63% | -$2.51M | ﹤0.01% | 1017 |
|
|
2024
Q2 | $4.42M | Sell |
610,029
-26,156
| -4% | -$190K | 0.01% | 649 |
|
|
2024
Q1 | $4.83M | Buy |
+636,185
| New | +$4.83M | 0.01% | 592 |
|
|
2019
Q3 | – | Sell |
-438,780
| Closed | -$522K | – | 922 |
|
|
2019
Q2 | $522K | Buy |
438,780
+218,280
| +99% | +$260K | ﹤0.01% | 805 |
|
|
2019
Q1 | $604K | Buy |
+220,500
| New | +$604K | 0.01% | 748 |
|